Opaleye Management Inc. Puma Biotechnology, Inc. Transaction History

Opaleye Management Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2019 May 15, 2019	SELL	$20.77 - $42.37 $2.08 Million - $4.24 Million	-100,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$20.07 - $46.7 $2.01 Million - $4.67 Million	100,000 New	100,000 $2.04 Million

30.2M

73.5K

18.5K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $127M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.